The U.S. Food and Drug Administration has approved the first rapid coronavirus d...
FILE PHOTO: A computer image created by Nexu Science Communication together with Trinity College in Dublin, shows a model structurally representative of a betacoronavirus which is the type of virus linked to COVID-19, better known as the coronavirus linked to the Wuhan outbreak, shared with Reuters on February 18, 2020. NEXU Science Communication/via REUTERS
Cepheid said in a statement it had received an emergency use authorization from the FDA for the test, which will be used primarily in hospitals and emergency rooms. The company plans to begin shipping it to hospitals next week, it said.
Indonesia Berita Terbaru, Indonesia Berita utama
Similar News:Anda juga dapat membaca berita serupa dengan ini yang kami kumpulkan dari sumber berita lain.
FDA Approves First Rapid 'Point-Of-Care' Coronavirus Test That Can Give Results in 45 MinutesThe tests will begin to ship next week with plans of using the product by the end of the month
Baca lebih lajut »
FDA approves new test that could detect coronavirus in about 45 minutesThe FDA announced its approval of the use of the first rapid diagnostic test that could detect coronavirus in approximately 45 minutes. Authorization was made Friday and tests will begin shipping next week, according to the company manufacturing the tests
Baca lebih lajut »
FDA grants 'emergency use' coronavirus test that can deliver results in 45 minutesCepheid has received emergency authorization from the Food and Drug Administration to use its rapid molecular test for point-of-care patients that can detect coronavirus in 45 minutes. This is the first coronavirus that can be conducted entirely at the point of care for patients and deliver results in less than an hour. Tests are typically sent to central reference labs that can take several days to deliver results.
Baca lebih lajut »
Philippines confirms 45 new coronavirus cases, bringing total to 307The Philippines' health ministry reported 45 more confirmed cases of corona...
Baca lebih lajut »